Tuesday, September 1, 2020

First randomised trial backs safety of common heart drugs in COVID-19 patients

Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to new research.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200901112216.htm

No comments:

Post a Comment